Speech-Language Pathologists in Elyria, OH Accepting Medicare

17 Speech-Language Pathologists found. Showing 1 - 17

Mrs. Susan Baker, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42101 Griswold Rd, Elyria, OH 44035 Phone: 440-284-8000

Rachel Marie Duffield Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 312 Gulf Rd, Elyria, OH 44035 Phone: 440-346-2646

Tracy M Roy, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 5th St, Elyria, OH 44035 Phone: 216-401-2882

Michele Krueger Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42101 Griswold Rd, Elyria, OH 44035 Phone: 440-284-8250

Mrs. Nuala Eppler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42101 Griswold Rd, Elyria, OH 44035 Phone: 440-284-8000

Jennifer Clayborn, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42101 Griswold Rd, Elyria, OH 44035 Phone: 440-284-8250

Mrs. Christina L. Neipp, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42101 Griswold Rd, Elyria, OH 44035 Phone: 440-284-8000

Mrs. Lynne Jones Knapp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1885 Lake Ave, Elyria, OH 44035 Phone: 440-324-3178    Fax: 440-324-3179

Barbara Jean Conrad Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1885 Lake Ave, Elyria, OH 44035 Phone: 440-324-5777

Erinn Kanyok, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1215 Middle Ave, Elyria, OH 44035 Phone: 440-284-8007

Mrs. Peggy M Joyce, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 E River St, Elyria, OH 44035 Phone: 440-284-8009

Mrs. Veronica G Buchanan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42101 Griswold Rd, Elyria, OH 44035 Phone: 440-284-8000

Cynthia L Rosenbaum, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42101 Griswold Rd, Elyria, OH 44035 Phone: 440-284-8000

Meena Louise Poe, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1212 Abbe Rd S, Elyria, OH 44035 Phone: 440-365-5200

Holly L Taylor, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 137 Winckles St, Elyria, OH 44035 Phone: 440-366-5993    Fax: 440-366-5313

Renee Banal Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1885 Lake Ave, Elyria, OH 44035 Phone: 440-324-3178

Brenda B Booth, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1885 Lake Ave, Elyria, OH 44035 Phone: 440-233-2271

News Archive

DePuy Spine, Lanx, Medtronic, Zimmer Spine and Codman support NREF's post-residency clinical fellowships

The NREF has reached agreements with Medtronic, Lanx and Zimmer Spine to provide funding to the NREF in support of the Foundation's post-residency clinical fellowship grant program. The NREF is pleased to report that it has renewed its agreements with Codman & Shurtleff, Inc. and DePuy Spine, Inc., who supported the inaugural year of the fellowship program in 2010.

MRI Patients in Canadian capital cities are getting the procedure sooner than regional areas

Patients in the Capital district who need an MRI are getting the procedure a lot sooner. The average wait time is now 45.2 days, almost three times less than the 148.2 days people were waiting last March. The wait time standard for elective MRI procedures is 42 days. Urgent or emergency MRIs are done immediately.

Actavis receives final FDA approval for Zolpidem ER Tablets

Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced.

Two experimental drugs aimed at controlling viral loads among HIV-positive people who have developed drug resistance show promise

Two experimental antiretroviral drugs, called TMC278 and elvitegravir, show promise in controlling the viral loads of HIV-positive people who have developed resistance to available drugs, researchers said Wednesday at the 14th Annual Conference on Retroviruses and Opportunistic Infections in Los Angeles, the Los Angeles Times reports.

Read more Medical News

› Verified 9 days ago